The delegation expressed a strong interest in expanding their business operations in The Gambia, signaling a potential boost to the country's healthcare sector.
The delegation's visit was met with enthusiasm by Mr Krubally, who highlighted the significant growth potential within the Gambian pharmaceutical market. "We are delighted to welcome this delegation and their commitment to expanding their operations in The Gambia," stated Mr Krubally. "Their expertise and commitment to quality will be invaluable in strengthening our healthcare infrastructure and ensuring greater access to affordable and high-quality medications for our people."
The Pakistani pharmaceutical manufacturing firm has expressed confidence in the Gambian market, citing its strategic location and growing demand for healthcare services. The delegation outlined plans to establish a local presence, potentially including manufacturing facilities, distribution networks, and partnerships with local healthcare providers.
The visit marks a significant step in the burgeoning economic ties between Pakistan and The Gambia. The expansion of Pakistani pharmaceutical operations in The Gambia is expected to bring numerous benefits to the country.
“The influx of Pakistani pharmaceuticals is anticipated to increase competition within the Gambian market, potentially driving down prices and making essential medications more accessible to a wider population,” the delegation stated.
“The establishment of local manufacturing facilities and distribution networks could lead to the creation of new jobs and contribute to the development of a more robust healthcare infrastructure within The Gambia.”
The visit signifies a positive development for both countries, as stakeholders highlight the potential for collaboration and shared economic growth, particularly in the crucial area of health.
The Gambian government has expressed its commitment to supporting the expansion of the Pakistani pharmaceutical factory, recognising its potential to significantly contribute to the country's development.
